VSEE HEALTH, INC. (VSEE) Form 8-K — Sep 9, 2026
VSee Health entered into a Strata Purchase Agreement with Clearthink Capital Partners on September 2, 2026, giving the company the right, at its sole discretion, to sell up to $5.0 million of its common stock to Clearthink over an approximately 36-month period. Draws are priced at 85% of the lowest daily closing price during the ten trading days preceding each purchase, with individual requests capped at the lesser of $1.0 million or 300% of the prior eight days' average trading volume. Clearthink's beneficial ownership is capped at 9.99% of outstanding shares, and it received 40,000 commitment shares at signing.
Key figures
- Term months
- 36
- Request spacing
- at least 5 trading days apart
- Max request size
- lesser of $1,000,000 or 300% of the average shares traded over the prior 8 trading days
- Min request size usd
- 25000
- Commencement deadline
- December 31, 2026
- Commitment amount usd
- 5000000
- Commitment fee shares
- 40000
- Purchase price formula
- 85% of the lowest daily closing price during the ten trading days preceding the purchase date
- Warrant exercise price
- 11.5
- Beneficial ownership cap
- 9.99% of outstanding common stock
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.